Association for
Applied Human
Pharmacology

  

Annual Meeting > Annual Meetings - Overview > Annual Meeting 2007 > Presentations 2007 

Presentations of the Annual Meeting 2007


D. Austin

ppt
Human pharmacology for biologicals – First into man studiesD._Austin_25.05.07.ppt (3 MB)

H. Caplain

ppt
Tolerability and safety: Predictability of QT prolongation in healthy subjects from preclinical experimentsCPI_AGAH_HC_042207.ppt (1 MB)

W. Cawello

pdf
Pharmacokinetics and bioavailability derived from various body fluidsW._Cawello__2__25.05.07.pdf (968 kB)

Ph. Danjou

pdf
Imaging in Early Drug DevelopmentPh._Danjou_21.06.07.pdf (4 MB)

F. Fliegert

pdf
Biomarkers in CNS drug developmentF._Fliegert__30.05.07.pdf (567 kB)

J. van Gerven

pdf
Development of Meaningful Interaction Studies for Combination TherapiesDevelopment_Of_Meaningful_Interaction_Studies_For_Combination_Therapies.pdf 

J. Grevel

ppt
PK and PD as predictors of clinical effectJ.Grevel_25.05.07.ppt (401 kB)

Ch. Schneider

pdf
Handling of First-in-man trials: regulatory rethink?Ch._Schneider_BAPU_WS_31.05.07.pdf (979 kB)

Ch. Schneider

pdf
Current regulatory developments relevant to humanCh._Schneider__2__WS_31.05.07.pdf (706 kB)

B. Schug

pdf
Need for a European Trial Data Base Introductory RemarksB._Schug_25.05.07.pdf (44 kB)

W. Seifert

pdf
Are pharma pipelines sustainable?Seifert_AGAH_AM2007_Sustainability_06X_2_1.pdf (2 MB)

H. Seyberth

ppt
Workshop: Designs of human pharmacology trials for paediatric populationsH._Seyberth_26.05.07_WS_I.ppt (4 MB)

M. Sibille

pdf
Interpretation of early safety signalsM._Sibille_25.05.07_EarlySafety.pdf (317 kB)

M. Sibille

pdf
Is priority to MTD - maximal tolerated dose - the best way?M._Sibille_25.05.07_MTD_Oxford_debate.pdf (286 kB)

Ch. Steffen

ppt
Clinical Trial Authorisation in Germany for First-in-Man Trials with NCEsC._Steffen_FIM.ppt (3 MB)

D. Tremblay

ppt
New regulatory requirements for first into man studies in FranceD._Tremblay_26.05.07.ppt (62 kB)

Page updated: 14-05-2009